DE69117853D1 - Topisch anzuwendendes pulverförmiges Arzneimittel, das zyklische AMP-Derivate enthält - Google Patents

Topisch anzuwendendes pulverförmiges Arzneimittel, das zyklische AMP-Derivate enthält

Info

Publication number
DE69117853D1
DE69117853D1 DE69117853T DE69117853T DE69117853D1 DE 69117853 D1 DE69117853 D1 DE 69117853D1 DE 69117853 T DE69117853 T DE 69117853T DE 69117853 T DE69117853 T DE 69117853T DE 69117853 D1 DE69117853 D1 DE 69117853D1
Authority
DE
Germany
Prior art keywords
topical
cyclic amp
product containing
containing cyclic
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69117853T
Other languages
English (en)
Other versions
DE69117853T2 (de
Inventor
Norio Takasugi
Eiichi Mafune
Toshiyuki Takayasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of DE69117853D1 publication Critical patent/DE69117853D1/de
Application granted granted Critical
Publication of DE69117853T2 publication Critical patent/DE69117853T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12—Face or body powders for grooming, adorning or absorbing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69117853T 1990-09-28 1991-09-26 Topisch anzuwendendes pulverförmiges Arzneimittel, das zyklische AMP-Derivate enthält Expired - Fee Related DE69117853T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25699190 1990-09-28

Publications (2)

Publication Number Publication Date
DE69117853D1 true DE69117853D1 (de) 1996-04-18
DE69117853T2 DE69117853T2 (de) 1996-09-12

Family

ID=17300207

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69117853T Expired - Fee Related DE69117853T2 (de) 1990-09-28 1991-09-26 Topisch anzuwendendes pulverförmiges Arzneimittel, das zyklische AMP-Derivate enthält

Country Status (8)

Country Link
US (2) US5405838A (de)
EP (1) EP0477943B1 (de)
JP (1) JP3454836B2 (de)
KR (1) KR0178796B1 (de)
AT (1) ATE135224T1 (de)
CA (1) CA2052193A1 (de)
DE (1) DE69117853T2 (de)
DK (1) DK0477943T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3783104B2 (ja) * 2004-03-31 2006-06-07 小林製薬株式会社 抗真菌性外用組成物
CA2704006A1 (en) * 2007-11-05 2009-05-14 Puretech Ventures Methods, kits, and compositions for administering pharmaceutical compounds
EP2648676A4 (de) 2010-12-06 2016-05-04 Follica Inc Verfahren zur behandlung von kahlköpfigkeit und zur förderung des haarwuchses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS497414A (de) * 1972-05-24 1974-01-23
US3849553A (en) * 1973-09-04 1974-11-19 Nelson Res & Dev Cyclic nucleotide therapeutic preparation
US4369181A (en) * 1981-08-05 1983-01-18 Sri International Process for treating proliferative skin diseases using certain 6,8-substituted ribofuranosylpurine-3',5'-cyclic phosphates
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
DE3786714T2 (de) * 1986-06-16 1994-03-10 Daiichi Seiyaku Co Therapeutisches Mittel für Hautgeschwüre.
JPH0759514B2 (ja) * 1986-12-18 1995-06-28 第一製薬株式会社 黄疸治療剤
CA1322957C (en) * 1988-03-30 1993-10-12 Hitoshi Yamauchi Cyclic amp derivative ointments

Also Published As

Publication number Publication date
KR0178796B1 (ko) 1999-03-20
DE69117853T2 (de) 1996-09-12
DK0477943T3 (da) 1996-07-22
JPH05186352A (ja) 1993-07-27
JP3454836B2 (ja) 2003-10-06
CA2052193A1 (en) 1992-03-29
EP0477943A1 (de) 1992-04-01
US5405838A (en) 1995-04-11
EP0477943B1 (de) 1996-03-13
US5424298A (en) 1995-06-13
ATE135224T1 (de) 1996-03-15
KR920005989A (ko) 1992-04-27

Similar Documents

Publication Publication Date Title
DE2966948D1 (en) Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations
ZA791732B (en) Carbazolyl-(4)-oxypropanolamine derivatives,preparation thereof and pharmaceutical compositions containing these compounds
DE2861318D1 (en) New derivatives of 4-phenyl-2-(2',2',2-trichlorethoxycarboxamido)-thiazole useful as medicaments, pharmaceutical compositions containing them and process for the preparation of these compounds
BE847095A (fr) Comprime pour la liberation controlee d'un medicament et sa preparation,
DE3062586D1 (en) 2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same
IL42781A (en) Derivatives of(4'-(3"-indolyl)piperidino)alkylarylketones,process for preparing them and pharmaceutical compositions containing same
IL51402A0 (en) 1,2-dithiole derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
ZA897541B (en) Benzoxazolinone derivatives,process for the preparation thereof and pharmaceutical compositions containing them
GB2044259B (en) Imidazole derivatives and salts thereof synthesis and pharmaceutical formulations
DE68901859D1 (de) 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
NO172490C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater
NL184468B (nl) 2-gesubstitueerde aminopyrimidinederivaten en farmaceutische preparaten die ze bevatten.
FR2324608A1 (fr) Derives de l'hydroxy-4 cyclopentene-2-one-1 utilisables pour la fabrication de medicaments, et preparation de ces substances
IL58676A (en) Histamine h2-antagonist pyrimid-4-one derivatives,their preparation and pharmaceutical compositions containing same
DE69117853D1 (de) Topisch anzuwendendes pulverförmiges Arzneimittel, das zyklische AMP-Derivate enthält
IL49931A (en) Pharmaceutical compositions comprising 1-phenyl-2,3,4,5-tetrahydro-1h-benzazepine derivatives and certain new such compounds
PH16253A (en) Dibenzazepine derivatives,pharmaceutical composition containing them and use of the compound
IL61175A (en) 4-(3-(1,2,3,4-tetrahydro-2-isoquinolyl)-2-hydroxypropyl)delta 2-1,2,4-oxadiazolin-5-one derivatives,process for their preparation and pharmaceutical compositions containing them
NZ193268A (en) 2-(pyrid-2-yl)-tetrahydrothiophene derivatives and pharmaceutical compositions
SE7808234L (sv) Nya dibenso(d,g)(1,3,6)dioxazocinderivat, sett for deras framstellning och lekemedelspreparat innehallande dessa foreningar
DE69101145D1 (de) (alkylthio-3-propyl)-3-benzothiazolinderivate, ihre herstellung und diese enthaltende arzneimittel.
IL56529A (en) N-benzopyranyl-3,4-dihydro-4-oxo-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide derivatives,their manufacture and pharmaceutical compositions containing them
NL7904772A (nl) Fenanthreenderivaten en werkwijze voor het bereiden van deze derivaten en van geneesmiddelen die ze bevatten.
IL58096A0 (en) 1,3-benzoxazine-2,4-dione derivatives their preparation and pharmaceutical compositions containing them
DE3761379D1 (de) 1,3-propandiaminderivate, ihre herstellung und sie enthaltende arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee